InvestSMART

MedAdvisor Limited (ASX: MDR) - Announcements

Current share price for MDR : $0.022 0.002 (10%)+

ASX company news and announcements for MedAdvisor Limited (MDR) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All MedAdvisor Limited (MDR) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than MedAdvisor Limited (MDR), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for MedAdvisor Limited (MDR)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
- Change in substantial holding 17 Apr 2024 4:34PM $0.255 $0.022 fallen by 91.37%
- Application for quotation of securities - MDR 8 Apr 2024 2:01PM $0.260 $0.022 fallen by 91.54%
- MDR - ASX Small and Mid-Cap Conference March 2024 27 Mar 2024 8:27AM $0.275 $0.022 fallen by 92%
- Application for quotation of securities - MDR 6 Mar 2024 9:40AM $0.310 $0.022 fallen by 92.90%
- MDR 1H FY24 Investor Webinar Recording 1 Mar 2024 9:42AM $0.315 $0.022 fallen by 93.02%
- MDR FY24 Half Year Results Update 29 Feb 2024 8:19AM $0.330 $0.022 fallen by 93.33%
- MDR FY24 Half Year Investor Presentation 29 Feb 2024 8:09AM $0.330 $0.022 fallen by 93.33%
- MDR Appendix 4D and FY24 Half Year Report 29 Feb 2024 8:09AM $0.330 $0.022 fallen by 93.33%
- MDR and BEN partner to bring conversational AI to patients 28 Feb 2024 8:14AM $0.290 $0.022 fallen by 92.41%
- MedAdvisor 1H FY24 Investor Webinar 19 Feb 2024 8:36AM $0.315 $0.022 fallen by 93.02%
- Becoming a substantial holder 16 Feb 2024 2:59PM $0.285 $0.022 fallen by 92.28%
- Q2 FY24 MDR Quarterly Update 30 Jan 2024 9:21AM $0.280 $0.022 fallen by 92.14%
- Application for quotation of securities - MDR 15 Jan 2024 9:39AM $0.270 $0.022 fallen by 91.85%
- Notification regarding unquoted securities - MDR 29 Nov 2023 1:04PM $0.225 $0.022 fallen by 90.22%
- Notification of cessation of securities - MDR 29 Nov 2023 12:55PM $0.225 $0.022 fallen by 90.22%
- Notification regarding unquoted securities - MDR 29 Nov 2023 12:53PM $0.225 $0.022 fallen by 90.22%
- MedAdvisor Solutions 2023 Results of AGM 28 Nov 2023 2:48PM $0.225 $0.022 fallen by 90.22%
- MedAdvisor Solutions 2023 AGM Chair Address 28 Nov 2023 8:22AM $0.225 $0.022 fallen by 90.22%
- MedAdvisor Solutions 2023 AGM Presentation 28 Nov 2023 8:21AM $0.225 $0.022 fallen by 90.22%
- MedAdvisor Solutions UK Update 28 Nov 2023 8:18AM $0.225 $0.022 fallen by 90.22%
- MDR delivers strong trading performance for 1H FY24 27 Nov 2023 8:47AM $0.205 $0.022 fallen by 89.27%
- Presentation at 2023 Bell Potter Healthcare Conference 16 Nov 2023 9:21AM $0.180 $0.022 fallen by 87.78%
- MedAdvisor awarded Scope of Practice pilot contract 14 Nov 2023 9:19AM $0.180 $0.022 fallen by 87.78%
- Change of Director's Interest Notice - Jim Xenos 10 Nov 2023 2:38PM $0.170 $0.022 fallen by 87.06%
- Application for quotation of securities - MDR 3 Nov 2023 9:11AM $0.200 $0.022 fallen by 89%

151 - 175 of 761 results

Page 7 of 31

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.